Horizon Surgical Systems, Inc., founded in 2021, develops AI-supported, robotics-enabled surgical platforms for ophthalmic microsurgery.
The company's flagship product, Polaris™, integrates AI-driven visualization with micro-robotic control to assist surgeons performing eye procedures. The platform combines computer vision and precision robotics to address the submillimeter tolerances and tremor-elimination requirements inherent to intraocular surgery. The system has completed a first-in-human study with 10 patients and achieved what the company describes as the world's first robotic-assisted cataract surgery.
The company raised $30 million in Series A funding to advance development of its surgical robotics platform. Founded by Jean-Pierre Hubschman and Jacob Rosen, experts in ophthalmology and medical robotics respectively, Horizon operates in the United States with a mission to scale robotic microsurgery techniques for broader clinical adoption.
Technical domains span surgical robotics systems engineering, real-time AI-based image processing for surgical visualization, micro-robotic control algorithms, and medical device development under regulatory constraints. Engineering work addresses problems at the intersection of precision mechatronics, computer vision, and clinical workflow integration, where system reliability and sub-millimeter accuracy are baseline requirements.